Ngā hua rapu - Henk Codrington

  • E whakaatu ana i te 1 - 5 hua o te 5
Whakamahine hua
  1. 1
    Is <sup>18</sup>F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer?

    Is <sup>18</sup>F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer? mā Tjeerd S. Aukema, Ingrid Kappers, Renato A. Valdés Olmos, Henk Codrington, Harm van Tinteren, Renée van Pel, Houke M. Klomp

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer

    Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer mā Eva E. Schaake, Ingrid Kappers, Henk Codrington, Renato A. Valdés Olmos, Hendrik J. Teertstra, Renée van Pel, Jacobus A. Burgers, Harm van Tinteren, Houke M. Klomp

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

    A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study mā Joachim G.J.V. Aerts, Henk Codrington, Nienke A. G. Lankheet, Sjaak A. Burgers, Bonne Biesma, Anne‐Marie C. Dingemans, Andrew Vincent, O. Dalesio, Harry J.M. Groen, Egbert F. Smit

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab mā Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer

    The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer mā Karlijn J.G. Schulkes, Esteban T.D. Souwer, Marije E. Hamaker, Henk Codrington, Simone van der Sar–van der Brugge, Jan‐Willem J. Lammers, Johanneke E.A. Portielje, Leontine J. R. van Elden, Frederiek van den Bos

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: